Key result
ECMO plus infliximab achieves complete recovery in ulcerative colitis-induced fulminant myocarditis.
Why the study?
Acute fulminant myocarditis induced by ulcerative colitis is a rare and severe condition requiring effective treatment strategies.
Case Report (n=1)
Extracorporeal life support combined with infliximab successfully treated acute fulminant myocarditis induced by ulcerative colitis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ECMO plus infliximab in UC-induced fulminant myocarditis; prospective studies needed before clinical adoption.
138 bpm.Initial echocardiography showed dilated left ventricular (LV) dimension and decreased LV ejection fraction (EF: 33%) with preserved LV tissue velocities (Fig. 1, Supplementary movie 1).We decided to apply extracorporeal membrane oxygenation (ECMO) for cardiac rest under impression of acute myocarditis because her coronary angiography showed normal coronary arteries (Fig. 2) in combination with global hypokinesia of LV.Follow up echocardiography performed the following day (Fig. 3, Supplementary movie 2) showed much depressed LV systolic function (EF: 10%) and myocardial tissue velocities (E': 10 → 3 cm/s, S': 6 → 2 cm/s).The 7th day after ECMO, massive hematochezia was occurred even with maintenance of corticosteroid (methylprednisolone 33 mg).Emergent sigmoidoscopy revealed diffuse maroon colored blood oozing from inflamed mucosa of transverse colon without discernable specific bleeding focus.Increased LV wall thickness (8 → 13 mm) and still depressed LV performance (EF: 16%, E': 2 cm/s, S': 3 cm/s) detected by echocardiography (Fig. 4, Supplementary movie 3), wherein we added infliximab (215 mg) infusion for uncontrolled inflammation.Two days later, removal of ECMO was possible because she sta- Successfully Treated Acute Fulminant Myocarditis
No takes yet. Share an insight, caveat, or question.
Kim et al. (2016) conducted a case report in Acute fulminant myocarditis induced by ulcerative colitis (n=1). Extracorporeal membrane oxygenation (ECMO) and infliximab was evaluated on Clinical recovery. A 28-year-old woman with acute fulminant myocarditis induced by ulcerative colitis was successfully treated and completely recovered following the application of ECMO and infliximab.
Synapse has enriched 10 related papers. Consider them for comparative context: